BioNTech SE (BNTX) Net Cash Flow (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Net Cash Flow data on file, last reported at -$2.8 billion in Q4 2025.

• For the quarter ending Q4 2025, Net Cash Flow fell 2045.25% year-over-year to -$2.8 billion; the trailing twelve-month figure through Dec 2025 stood at -$2.5 billion (down 16.5% YoY), and the FY2025 full-year result was -$2.3 billion, down 13.77% from the prior year.
• Net Cash Flow slipped to -$2.8 billion in Q4 2025, from -$182.5 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $5.0 billion in Q1 2022 to a low of -$2.9 billion in Q1 2024.
• A 5-year average of $459.2 million and a median of $243.1 million in 2024 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow surged 61737815.84% in 2021 and slumped 2045.25% in 2025, its largest moves.
• Tracing BNTX's Net Cash Flow over 5 years: stood at $342.5 million in 2021, then surged by 175.69% to $944.2 million in 2022, then plunged by 311.61% to -$2.0 billion in 2023, then soared by 107.28% to $145.4 million in 2024, then sank by 2045.25% to -$2.8 billion in 2025.
• Business Quant data shows BNTX's Net Cash Flow at -$2.8 billion in Q4 2025, -$182.5 million in Q3 2025, and $77.9 million in Q2 2025.